The Effect of an Acute Dose of Ticagrelor or Clopidogrel and of Treatment for 14 Days on Ischemia-reperfusion Induced Endothelial Dysfunction of the Forearm Vasculature in Healthy Male Subjects.
Phase of Trial: Phase IV
Latest Information Update: 27 Sep 2016
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel
- Indications Peripheral arterial disorders
- Focus Pharmacokinetics
- 19 Sep 2016 Status changed from recruiting to completed.
- 27 Oct 2015 New trial record